Cargando…

Assessment of the usefulness of anti-Wb123 antibody for post-elimination surveillance of lymphatic filariasis

BACKGROUND: The World Health Organization has targeted lymphatic filariasis (LF) for elimination as a public health problem and recommends, among other measures, post-elimination surveillance of LF. The identification of sensitive and specific surveillance tools is therefore a research priority. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorkenoo, Ameyo Monique, Koba, Adjaho, Halatoko, Wemboo A., Teko, Minongblon, Kossi, Komlan, Yakpa, Kossi, Bronzan, Rachel N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789272/ https://www.ncbi.nlm.nih.gov/pubmed/33407812 http://dx.doi.org/10.1186/s13071-020-04535-y

Ejemplares similares

Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010–2015
por: Dorkenoo, Monique Ameyo, et al.
Publicado: (2018)

Monitoring migrant groups as a post-validation surveillance approach to contain the potential reemergence of lymphatic filariasis in Togo
por: Dorkenoo, Monique Ameyo, et al.
Publicado: (2021)

Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo
por: Bronzan, Rachel N., et al.
Publicado: (2018)

A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
por: Sodahlon, Yao K., et al.
Publicado: (2013)

Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis
por: Pastor, André Filipe, et al.
Publicado: (2018)

Evaluation of the performance of advantage P.f. malaria Card(®) and advantage malaria Pan + Pf Card(®), two rapid diagnostic tests for parasitological confirmation of malaria cases in field situation in Togo
por: Teou, Diwaba Carmel, et al.
Publicado: (2023)

Potential Emergence of Plasmodium Resistance to Artemisinin Induced by the Use of Artemisia annua for Malaria and COVID-19 Prevention in Sub-African Region
por: Ataba, Essoham, et al.
Publicado: (2021)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China
por: Fang, Yuan, et al.
Publicado: (2019)

Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013
por: Dorkenoo, Améyo M., et al.
Publicado: (2016)

Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis
por: Harris, Julie R., et al.
Publicado: (2017)

Pilot Assessment of Soil-Transmitted Helminthiasis in the Context of Transmission Assessment Surveys for Lymphatic Filariasis in Benin and Tonga
por: Chu, Brian K., et al.
Publicado: (2014)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Implementation of Influenza-like illness Sentinel Surveillance in Togo
por: Maman, Issaka, et al.
Publicado: (2014)

Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
por: Dorkenoo, Monique A., et al.
Publicado: (2018)

Progress from morbidity control to elimination as a public health problem of schistosomiasis and the status of soil-transmitted helminth infection in Togo: a second impact assessment after ten rounds of mass drug administration
por: Dorkenoo, Ameyo M., et al.
Publicado: (2023)

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
por: Michael, Edwin, et al.
Publicado: (2018)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
por: Johanns, Saskia I., et al.
Publicado: (2022)

The use of dried tube specimens of Plasmodium falciparum in an external quality assessment programme to evaluate health worker performance for malaria rapid diagnostic testing in healthcare centres in Togo
por: Dorkenoo, Ameyo M., et al.
Publicado: (2021)

Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lomé Togo, 2016
por: Halatoko, Wemboo Afiwa, et al.
Publicado: (2019)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Population Migration: Implications for Lymphatic Filariasis Elimination Programmes
por: Ramaiah, K. D.
Publicado: (2013)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone
por: Bah, Yakuba M., et al.
Publicado: (2020)

Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020)

Caring for patients in the global programme to eliminate lymphatic filariasis
por: Mackenzie, Charles D, et al.
Publicado: (2020)

Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
por: Joseph, Hayley, et al.
Publicado: (2011)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

IgG(4) antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis
por: Greene, Sarah E., et al.
Publicado: (2023)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Global Elimination of Lymphatic Filariasis: Addressing the Public Health Problem
por: Addiss, David G.
Publicado: (2010)

Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion”
por: Addiss, David G.
Publicado: (2013)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2017)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b73cp775fnra55taa2e2fvt0c3